GSK plc Transaction Notification

2026-05-19SEC Filing 6-K (0001654954-26-005102)

This filing reports on transactions by GSK plc involving American Depositary Shares (ADS). Dr. Hal Barron, a Non-Executive Director, acquired notional ADSs on May 15, 2026, valued at $49.6700 per ADS, totaling 2,300.572 ADSs. This acquisition occurred within his GSK Executive Supplemental Savings Plan account due to dividend reinvestment. Similarly, James Ford, SVP and Group General Counsel, and Maya Martinez-Davis, President of US, also acquired notional ADSs on the same date and at the same price, for 54.387 and 82.387 ADSs respectively, under similar dividend reinvestment conditions within their respective savings plans. All transactions took place on the New York Stock Exchange (XNYS). This is an initial notification for all parties involved.

Ticker mentioned:GSK